B. Biol Psychiatry 72:537–547Artigas F, Romero L, de Montigny C, Blier P (1996) Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists. MGC has consulted for Lundbeck and received compensation. and Fryer, Tim J Neurochem 105:1091–1099Sanchez C (2006) The pharmacology of citalopram enantiomers: the antagonism by R-citalopram on the effect of S-citalopram. Pharmacokinetics. Felmingham, Kim L. 2019.
JPRJ is the grateful recipient of an individual grant from The Lundbeck Foundation of Denmark. and Mitchell, Derek Antal, Peter Suckling, John Wang, Chenbo Blair, R. James Kirsch, Peter 2016. Eur J Pharmacol 433:141–150Iyengar S, Hipskind PA, Gehlert DR, Schober D, Lobb KL, Nixon JA, Helton DR, Kallman MJ, Boucher S, Couture R, Li DL, Simmons RM (1997) LY303870, a centrally active neurokinin-1 antagonist with a long duration of action. Gonda, Xenia Psychopharmacology 85:367–370Storustovu S, Sanchez C, Porzgen P, Brennum LT, Larsen AK, Pulis M, Ebert B (2004) R-citalopram functionally antagonises escitalopram in vivo and in vitro: evidence for kinetic interaction at the serotonin transporter. Gonda, Xenia BMJ 341:c4737Fish EW, Faccidomo S, Gupta S, Miczek KA (2004) Anxiolytic-like effects of escitalopram, citalopram, and R-citalopram in maternally separated mouse pups. 2016. Tait, Roger Fabbri, Chiara Subscription will auto renew annually.Aan Het Rot M, Zarate CA Jr, Charney DS, Mathew SJ (2012) Ketamine for depression: where do we go from here? Han, Shihui
2016. Clarke, Hannah F. Email your librarian or administrator to recommend adding this journal to your organisation's collection.Email your librarian or administrator to recommend adding this journal to your organisation's collection.Full text views reflects the number of PDF downloads, PDFs sent to Google Drive, Dropbox and Kindle and HTML full text views.Abstract views reflect the number of visits to the article landing page. Goldman, David
McCaffrey, Daniel Pharmacol Ther 124:195–206Meyer JH, Wilson AA, Sagrati S, Hussey D, Carella A, Potter WZ, Ginovart N, Spencer EP, Cheok A, Houle S (2004) Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study. Yu, Henry Intravenous Infusion (Drip Method): To control postpartum bleeding, 10 to 40 units of Oxytocin may be … Wang, Danyang and Arch Gen Psychiatry 69:572–579Gitter BD, Waters DC, Bruns RF, Mason NR, Nixon JA, Howbert JJ (1991) Species differences in affinities of non-peptide antagonists for substance P receptors. Clin Ther 29:2319–2332Zhong H, Hansen KB, Boyle NJ, Han K, Muske G, Huang X, Egebjerg J, Sanchez C (2009) An allosteric binding site at the human serotonin transporter mediates the inhibition of escitalopram by R-citalopram: kinetic binding studies with the ALI/VFL-SI/TT mutant. Ma, Yina
2019. 2016. and McCaffrey, Daniel Subscription will auto renew annually.Over 10 million scientific documents at your fingertips J Pharmacol Exp Ther 280:774–785Jacobsen JP, Nielsen EO, Hummel R, Redrobe JP, Mirza N, Weikop P (2008) Insensitivity of NMRI mice to selective serotonin reuptake inhibitors in the tail suspension test can be reversed by co-treatment with 5-hydroxytryptophan.
Wager, Tor D.
2016. Rand, David G Liu, Yi Bagdy, Gyorgy
2016.
Luo, Siyang Aigbirhio, Franklin I.
Control of Postpartum Uterine Bleeding.
Brandl, Eva J. Suckling, John The mother and the fetus must be evaluated by the responsible physician. J Neuroendocrinol 24:609–628Mansari ME, Wiborg O, Mnie-Filali O, Benturquia N, Sanchez C, Haddjeri N (2007) Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies. Am J Psychiatry 161:826–835Michelson D, Adler LA, Amsterdam JD, Dunner DL, Nierenberg AA, Reimherr FW, Schatzberg AF, Kelsey DK, Williams DW (2007) Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled study. Bagdy, Gyorgy Raab, Kyeon Rationale. Jaksa, P. Ren, Xue-Qun and and Zhang, Wenxia Close this message to accept cookies or find out how to Selective serotonin reuptake inhibitors (SSRIs), such as citalopram, which selectively block serotonin transporter (5-HTT) activity, are widely used in the treatment of depression and anxiety disorders. Spina, Edoardo Deng, Tong Lett, Tristram A. A randomised placebo-controlled study on healthy volunteersPharmacokinetics and bioavailability comparison of generic and branded citalopram 20 mg tablets: an open-label, randomized-sequence, two-period crossover study in healthy Chinese CYP2C19 extensive metabolizersA psychobiological model of temperament and characterDevelopment and validation of brief measures of positive and negative affect: the PANAS scalesRevision of the Chinese Facial Affective Picture SystemSerotonin transporter genotype (5-HTTLPR): effects of neutral and undefined conditions on amygdala activationSerotonin transporter genetic variation and the response of the human amygdalaA susceptibility gene for affective disorders and the response of the human amygdalaShort-term SSRI treatment normalises amygdala hyperactivity in depressed patientsHow do you feel?
You can also search for this author in Outhred, Tim Roberts, Angela C. Walter, Henrik Wang, Yun-Yun and Blair, R. James